The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

With VKTX surging on clinical results and NVO investing to cement market share, investors face a high-stake GLP-1 showdown.

Research even suggests it can change users' sense of smell, and other common side effects include diarrhoea, nausea, 'sulphur ...

The 72-year-old reality TV personality's clothes looked loose on her body during an outing in city after she recently admitted Ozempic had left her unable to gain weight.

The music mogul has sparked fears for her wellbeing amongst fans, appearing gaunt and thin in latest Instagram reel defending ...

FAT JABS have taken the nation’s waistline by storm – trimming inches and helping thousands shed weight, and fast. But it ...

New research reveals Ozempic users may face twice the risk of developing a rare but irreversible form of vision loss. Danish health officials are sounding the alarm as cases of NAION surge among ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.